年度報告 2024 ZHONGGUANCUN SCIENCE-TECH LEASING CO., LTD. 中關村科技租賃股份有限公司 目錄 | 公司簡介 | 2 | | --- | --- | | 公司資料 | 3 | | 公司業績 | 5 | | 董事長致辭 | 6 | | 總經理致辭 | 9 | | 管理層討論與分析 | 12 | | 董事、監事及高級管理層簡歷 | 56 | | 企業管治報告 | 68 | | 董事會報告 | 97 | | 監事會報告 | 119 | | 社會、環境及管治報告 | 122 | | 獨立核數師報告 | 144 | | 合併財務報表及附註 | 150 | | 釋 義 | 251 | 公司簡介 中 關 村 科 技 租 賃 股 份 有 限 公 司（股 份 代 號：1601.HK）是 中 關 村 發 展 集 團 旗 下 上 市 平 臺，於2012 年11月 在 北 京 成 立。我 們 以「發 現 並 培 育 獨 角 獸，成 就 科 技 創 業 者 的 夢 想」為 使 命，聚 焦 支 持 中 國 硬 科 技 企 業 的 技 術 轉 化 與 成 長，打 通 其 科 技 成 果 產 業 ...

2024 年報 2024 年報 目錄 | 公司資料 | 3 | | --- | --- | | 本集團之主要業務 | 4 | | 財務摘要 | 6 | | 主席報告 | 14 | | 管理層討論及分析 | 16 | | 董事及高層管理人員簡介 | 28 | | 董事報告 | 32 | | 企業管治報告 | 44 | | 獨立核數師報告 | 60 | | 綜合財務報表 | | | 綜合損益表 | 66 | | 綜合全面收入表 | 68 | | 綜合財務狀況表 | 69 | | 綜合權益變動表 | 71 | | 綜合現金流量表 | 73 | | 財務報表附註 | 75 | | 根據香港聯合交易所有限公司證券上市規則披露之交易 | 192 | | 本集團持有之主要物業 | 201 | 2 粵海投資有限公司 | 2024 年年報 白 濤女士 （主席） 林鐵軍先生 （副主席） 温引珩先生 （董事總經理） 曾翰南先生 （副總經理） 梁元娟女士 （財務總監） 非執行董事 蔡 勇先生 馮慶春先生 獨立非執行董事 陳祖澤博士 金紫荊星章、太平紳士 馮華健先生 銀紫荊星章、御用大律師、資深大律師、太平紳士 鄭慕智博士 大紫荊勳賢 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不 負責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告 全部或任何部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責 任。 澄清公告－ 截至二零二四年十二月三十一日止 年度全年業績公告 茲提述Neway Group Holdings Limited中星集團控股有限公司*（「本公司」）日期 為二零二五年三月二十六日之公告，內容有關本公司截至二零二四年十二月 三十一日止年度之全年業績（「全年業績公告」）。除另有界定者外，本公告所用 詞彙與全年業績公告所界定者具有相同涵義。 董事會謹此澄清全年業績公告之若干手民之誤，其修訂內容以底線標示如下： 1. 於全年業績公告第22頁第五段： 本集團存在信貸集中風險，原因是應收貸款總額共計約19,400,000港元 （二零二三年度：約25,400,000港元）的63%（二零二三年度：53%）乃結欠 自兩名（二零二三年度：三名）獨立第三方。五大借款人的應收貸款賬面總 值約為25,900,000港元（二零二三年度：32,800,000港元）。 * 僅供識別 1 NEWAY GROUP HOLDI ...

（於中華人民共和國註冊成立的股份有限公司） 股份代號：6190 2024 年度報告 1. 基本資料 | 法定中文名稱 | ： | 九江銀行股份有限公司* | | --- | --- | --- | | 法定英文名稱 | ： | Bank of Jiujiang Co., Ltd.* | | 法定代表人 | ： | 周時辛 | | 公司秘書 | ： | 黃偉超 | | 授權代表 | ： | 肖璟 | | H股股票上市交易所 | ： | 香港聯合交易所有限公司 | | 股份簡稱 | ： | 九江銀行 | | 股份代號 | ： | 6190 | | 統一社會信用代碼 | ： | 9136040070552834XQ | | 金融許可證號 | ： | B0348H336040001 | | 註冊資本 | ： | 人民幣2,847,367,200元 | | 註冊及辦公地址 | ： | 中國江西省九江市濂溪區長虹大道619號（郵編：332000） | | 香港主要營業地址 | ： | 香港灣仔皇后大道東248號大新金融中心40樓 | | 聯絡方式 | ： | 電話：+86(792)7783000-1101 傳真：+86( ...

2025年第一季度報告 重要內容提示 公司董事會、監事會及董事、監事、高級管理人員保證季度報告內容的真實、準確、 完整，不存在虛假記載、誤導性陳述或重大遺漏，並承擔個別和連帶的法律責任。 公司負責人、主管會計工作負責人及會計機構負責人（會計主管人員）保證季度報告 中財務信息的真實、準確、完整。 第一季度財務報表未經審計。 1 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何 部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 一、釋義 本公司、公司、 一拖股份 指 第一拖拉機股份有限公司 2 中國一拖 指 中國一拖集團有限公司（本公司控股股東） 中國證監會 指 中國證券監督管理委員會 聯交所 指 香港聯合交易所有限公司 A股 指 經中國證監會批准向境內投資者及合資格境外投資者 發行、在中國境內證券交易所上市、以人民幣標明股 票面值、以人民幣認購和進行交易的普通股 H股 指 經中國證監會批准向境外投資者發行、經聯交所批准 上市、以人民幣標明股票面值、以港幣認購和進行交 易的普通股 二、主要財務數據 （一） ...

Financial Performance - Revenue increased from RMB 19,532.2 million in 2023 to RMB 20,748.6 million in 2024, a year-on-year increase of 6.2%[10] - Gross profit rose from RMB 12,663.4 million in 2023 to RMB 13,764.8 million in 2024, reflecting an 8.7% year-on-year growth[10] - Net profit increased from RMB 3,290.4 million in 2023 to RMB 3,654.1 million in 2024, marking an 11.1% year-on-year rise[10] - Total assets as of December 31, 2024, were RMB 35,725.7 million, compared to RMB 36,194.7 million in 2023[8] - Total equity increased to RMB 27,407.4 million in 2024 from RMB 26,334.3 million in 2023[8] - Profit before tax rose by 14.4% from RMB 4,850.3 million in 2023 to RMB 5,549.7 million in 2024[45] - Other income and net gains decreased by 11.7% from RMB 1,659.5 million in 2023 to RMB 1,465.1 million in 2024, primarily due to reduced government subsidies[39] - Cash and cash equivalents amounted to RMB 9,321.2 million as of December 31, 2024, including unrestricted time deposits and similar cash-like assets[49] - The debt-to-equity ratio improved from 0.36 in 2023 to 0.32 in 2024, indicating a stronger capital structure[52] Market and Product Development - The company launched new nutritional products such as "Supernova Cheese" and "Aiben Dynamic Protein Powder" to meet personalized nutrition needs[11] - The company is committed to product innovation and aims to lead the all-age nutrition sector, aligning with its mission to deliver love through nutrition[15] - Revenue from infant formula products accounted for 91.9% of total revenue in 2024, amounting to RMB 19,061.6 million, a 6.6% increase from the previous year[34] - The company has a strong focus on the infant nutrition market, with leadership roles held by former executives from Nestlé and Coca-Cola[77] - The company is actively involved in research and development to innovate new products in the health and nutrition sector[71] Marketing and Sales Strategy - The company held over 920,000 face-to-face seminars during the fiscal year ending December 31, 2024, to maximize consumer engagement[28] - The company plans to continue enhancing its marketing strategies, focusing on both online and offline channels to strengthen brand association[27] - The company has a distribution network of over 2,800 offline customers covering more than 77,000 retail points, with 77.1% of total revenue from dairy products generated through these sales channels[23] Corporate Social Responsibility and Governance - The company was recognized in the "2024 ESG Excellence Practice Report" and ranked among the "Top 100 ESG Listed Companies in China" for its achievements in ESG development[12] - The company participated in drafting three national standards related to "green manufacturing" to promote sustainable development[12] - The company made charitable donations of approximately RMB 26.4 million for the year ending December 31, 2024[112] Future Outlook and Strategic Plans - China Feihe aims to enhance its global brand influence and expand overseas markets, focusing on becoming a "global Feihe" through continuous innovation in maternal milk research and all-age nutrition[15] - The company plans to continue focusing on independent innovation, particularly in areas such as breast milk research and brain development research, to enhance its product offerings[62] - Market expansion plans include entering two new international markets by Q3 2024[68] - The company is considering strategic acquisitions to enhance its market position, with a budget of $100 million set aside for potential deals[69] Shareholder Information and Dividends - The company plans to distribute a final dividend of HKD 0.1632 per share for the year ending December 31, 2024, totaling approximately HKD 1,479,775,000 (equivalent to about RMB 1,366,120,000) pending shareholder approval[101] - The company aims to maintain a dividend policy of distributing no less than 30% of net profit for each financial year, subject to future investment plans[102] - As of December 31, 2024, the company's distributable reserves amount to approximately RMB 13,172.6 million, of which RMB 1,366.1 million is proposed for the final dividend[111] Management and Governance Structure - The management team has extensive experience, with key executives having over 30 years in the dairy industry[65] - The board of directors includes independent members with diverse backgrounds in finance, healthcare, and management, ensuring robust governance[80] - The company has established a strong foundation in environmental, social, and governance (ESG) practices, with dedicated committees overseeing these initiatives[80] Financial Management and Capital Allocation - The company plans to allocate HKD 2,621.9 million for offshore debt repayment, with HKD 208.3 million remaining to be used by December 31, 2025[117] - Potential acquisition opportunities are estimated at HKD 1,310.9 million, with no amount yet utilized[117] - The company has unutilized funds amounting to HKD 1,488.1 million, which is expected to be fully utilized by December 31, 2025[118]

股份代號：1809 浦林成山控股有限公司 (於開曼群島註冊成立的有限公司) 2024 年報 PURSUE EXCELLENCE 2024ANNUAL REPORT Stock Code：1809 PRINX CHENGSHAN HOLDINGS LIMITED (Incorporated in the Cayman lslands with limited liability) ANNUAL REPORT 2024 年報 目 錄 公司資料 2 財務摘要 4 本集團概覽 7 主席報告 9 管理層討論及分析 12 董事及高級管理層 41 董事會報告 49 企業管治報告 80 獨立核數師報告 綜合損益表 綜合全面收益表 綜合財務狀況表 綜合權益變動表 綜合現金流量表 綜合財務報表附註 101 106 107 108 110 112 113 浦林成山控股有限公司 二零二四年年度報告 公司資料 董事會 執行董事 車寶臻先生 （行政總裁） 石富濤先生 曹雪玉女士（於2024年3月28日離任） 姜錫洲先生（於2024年3月28日委任） 非執行董事 車宏志先生 （主席） 王雷先生（於2024年3月28日離任） 邵全峰先生 王 ...

香港聯合交易所有限公司（「聯交所」）GEM的特色 執行董事 GEM的定位，乃為相比起其他在聯交所上市的公司帶有較高投資風險的中小型公司提供一個上市的市場。有意投資的 人士應了解投資於該等公司的潛在風險，並應經過審慎周詳的考慮後方作出投資決定。 由於 GEM上市公司一般為中小型公司，在 GEM買賣的證券可能會較於聯交所主板買賣的證券承受較大的市場波動風 險，同時無法保證在GEM買賣的證券會有高流通量的市場。 香港交易及結算所有限公司及聯交所對本報告的內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確表示 概不就因本報告全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 本報告乃根據 GEM證券上市規則（「GEM上市規則」）之規定而刊載，旨在提供有關吉盛集團控股有限公司（「本公司」） 的資料，本公司董事（「董事」）願就本報告共同及個別地承擔全部責任。董事在作出一切合理查詢後確認，就彼等所深 知及確信，本報告所載資料在所有重要方面均準確及完整，並無誤導或欺詐成分，且並無遺漏任何其他事項，致使當 中所載任何陳述或本報告有所誤導。 目 錄 | 公司資料 | 2 | | --- | --- | ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內 容 概 不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不對因本公告全部或任何部份內容而產生或因倚賴該等內容而引致的 任 何 損 失 承 擔 任 何 責 任。 JIANGSU EXPRESSWAY COMPANY LIMITED 江蘇寧滬高速公路股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：00177） 2025年第一季度報告 單 位：元 幣 種：人 民 幣 本報告期 本 公 司 董 事 會 及 全 體 董 事 保 證 本 公 告 內 容 不 存 在 任 何 虛 假 記 載、誤 導 性 陳 述 或 者 重 大 遺 漏，並 對 其 內 容 的 真 實 性、準 確 性 和 完 整 性 承 擔 法 律 責 任。 重要內容提示 公 司 董 事 會、監 事 會 及 董 事、監 事、高 級 管 理 人 員 保 證 季 度 報 告 內 容 的 真 實、準 確、完 整，不 存 在 虛 假 記 載、誤 導 性 陳 述 或 重 大 遺 漏，並 承 擔 個 別 和 連 帶 的 法 律 責 任 ...

Financial Performance - Revenue for 2024 reached RMB 5,538.8 million, a 57.2% increase from RMB 3,524.1 million in 2023[6] - Gross profit for 2024 was RMB 4,546.9 million, reflecting a 54.3% growth compared to RMB 2,947.1 million in 2023[6] - Net profit attributable to shareholders for 2024 was RMB 2,062.3 million, up 42.1% from RMB 1,451.8 million in 2023[6] - The company achieved a total revenue of RMB 55.39 billion, representing a year-on-year growth of 57.2%[11] - Adjusted net profit reached RMB 21.52 billion, with a year-on-year increase of 46.5%[11] - Total revenue for the year ended December 31, 2024, reached RMB 5,538.8 million, a 57.2% increase from RMB 3,524.1 million for the year ended December 31, 2023[31] - Direct sales revenue grew over 70% year-on-year in 2024, becoming a major driver of business growth[10] - Direct sales and distribution channels generated revenues of RMB 4,134.2 million and RMB 1,404.6 million, accounting for 74.6% and 25.4% of total revenue, respectively[26] - Professional skin care products accounted for 77.7% of total revenue in 2024, with RMB 4,302.3 million in sales, up from 75.1% and RMB 2,647.3 million in 2023[32] - Total sales cost for 2024 was RMB 991.9 million, a 71.9% increase from 2023, primarily due to increased sales volume and material costs[43] - Gross profit for 2024 was RMB 4,546.9 million, a 54.3% increase from 2023, with a gross margin of 82.1%, down from 83.6% in 2023[44] Research and Development - Research and development investment increased by 42% in 2024, with 74 new patents and applications filed[9] - Research and development expenditure amounted to RMB 106.5 million, a 42.1% increase year-on-year, accounting for 1.9% of total revenue[13] - The company has 188 ongoing research projects and holds 167 patents, with 74 new patents granted during the reporting period[13] - The company plans to increase R&D investment and prepare for the commercialization of three categories of medical devices by 2025[30] Market Expansion and Product Development - The company established a multi-brand development matrix, launching innovative products that gained consumer favor[10] - The company is actively expanding its international market presence, aiming to bring its products to global consumers[11] - The company is focusing on the development of innovative and competitive products to meet diverse consumer needs[11] - The "可復美" brand has developed a comprehensive product matrix, including a major medical device series and four skincare series, enhancing its market presence[16] - The company launched the new "Kefumei Focus Series" targeting skin conditions such as dullness and acute fatigue, with the "Kefumei Focus Cream" achieving top rankings in sales during the 2024 Double Eleven shopping festival[19] - The company expanded its product offerings with the "Kefumei Order Series" and "Kefumei Ton Ton Series," addressing various consumer needs and enhancing brand reach[20] Sales and Distribution Channels - Online channel GMV growth during the 2024 618 promotion exceeded 60% for Kefu Mei and 100% for Keli Jin, and during the 2024 Double Eleven promotion, growth exceeded 80% and 150%, respectively[25] - Direct sales through DTC online stores generated revenue of RMB 3,587.2 million, a 66.5% increase from 2023, accounting for 64.8% of total revenue in 2024[34] - Revenue from online direct sales on e-commerce platforms reached RMB 377.1 million, up 112.5% year-over-year, representing 6.8% of total revenue in 2024[35] - Offline direct sales revenue was RMB 169.9 million, a 92.0% increase from 2023, making up 3.0% of total revenue in 2024[36] - Sales to distributors amounted to RMB 1,404.6 million, reflecting a 27.3% increase year-over-year, contributing 25.4% to total revenue in 2024[37] Corporate Governance and Management - The company has adopted the corporate governance code as per the Listing Rules Appendix C1 and has complied with all applicable code provisions during the reporting period, except for deviation from code provision C.2.1[150] - The board of directors consists of 4 executive directors and 3 independent non-executive directors, ensuring compliance with the requirement of having at least one independent non-executive director with appropriate professional qualifications or accounting expertise[151] - The company has established four board committees, including the audit committee, nomination committee, remuneration committee, and corporate governance committee[165] - The company has implemented a training program for directors and senior management regarding compliance with Chinese laws and regulations, with a specific training session held in July 2024[188] - The company has established an ESG governance committee to regularly report on ESG-related matters to the board[66] Employee and Shareholder Engagement - The company employed 1,758 full-time staff, with 37.0% in production, 10.6% in R&D, 32.2% in sales and marketing, and 20.2% in general and administrative roles[105] - The company emphasizes effective communication with shareholders through financial reports, annual general meetings, and timely disclosures on its website[196] - The company encourages shareholder participation in meetings and ensures proper notice is given at least 21 days before annual meetings[197] - The company provides communications in both English and Chinese to facilitate shareholder understanding[198] - The company has a dedicated website (www.xajuzi.com) for regular updates and communication with shareholders and investors[199] Social Responsibility and Community Engagement - The company engaged in social responsibility initiatives, donating products valued at over RMB 14 million during various charitable activities[28] - The "Kefumei" brand introduced a bottle recycling program and engaged in various community outreach activities to promote scientific skincare[23] Risk Management - The company faces various operational risks, including changes in the regulatory environment in China, the ability to provide quality products, and competition from other market participants[185] - The company has implemented a risk management and internal control system to address identified risks, which includes policies and procedures deemed suitable for its operations[185] - Financial risks faced by the company include foreign exchange risk, credit risk, and liquidity risk, with the main financial instruments being cash and cash equivalents[187] - The company conducts annual risk factor identification and assessment, reviewing the effectiveness of risk assessment and control measures[186] Dividends and Shareholder Returns - The board proposed a final dividend of RMB 0.6021 per share and a special dividend of RMB 0.5921 per share[6] - The company's undistributed profits available for distribution to shareholders amounted to RMB 4,057 million as of the reporting period end[75]